| Rena C Lewis, | |
|
2617 Highway 31 S, Pelham, AL 35124-1322 | |
| (205) 664-1575 | |
| Not Available |
| Full Name | Rena C Lewis |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 38 Years |
| Location | 2617 Highway 31 S, Pelham, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265444293 | NPI | - | NPPES |
| U34042 | Other | AL | HEALTHSPRING OF AL |
| 925493 | Other | AL | BLOCK VISION |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152WP0200X | Optometrist - Pediatrics | S599TA190 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jessica Palmer, O.d., Llc | 0345340204 | 3 |
| Eyecare Associates, Inc. | 0749254001 | 56 |
News Archive
Researchers from the University of Hawaii - Manoa (UHM) School of Ocean and Earth Science and Technology (SOEST), Lawrence Livermore National Laboratory, Lawrence Berkeley National Laboratory, and University of California - Berkeley discovered that interplanetary dust particles (IDPs) could deliver water and organics to the Earth and other terrestrial planets.
People with arthritis experienced a ‘roller coaster' of emotions and saw their symptoms worsen during the Covid-19 lockdown – according to research from the University of East Anglia.
An alarming 22 percent of U.S. children live in poverty, which can have long-lasting negative consequences on brain development, emotional health and academic achievement. A new study, published July 20 in JAMA Pediatrics, provides even more compelling evidence that growing up in poverty has detrimental effects on the brain.
Lipocine Inc. announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent applications in support of its oral testosterone product for hypogonadism, also known as low testosterone (low T). These applications cover Lipocine's novel oral testosterone product (LPCN 1021) being developed to overcome the issues with currently marketed topical, parenteral, and transdermal testosterone products.
All approved therapy regimens to treat patients with hepatitis C are based on interferon, which must be injected. In this clinical trial to be presented at the annual meeting of the American Association for the Study of Liver Diseases, researchers treated patients - both treatment naive and experienced patients - with a twice daily oral combination therapy of a nucleoside polymerase and protease inhibitor.
› Verified 9 days ago
| Provider Name | Eyecare Associates, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1710012877 PECOS PAC ID: 0749254001 Enrollment ID: O20040823000825 |
News Archive
Researchers from the University of Hawaii - Manoa (UHM) School of Ocean and Earth Science and Technology (SOEST), Lawrence Livermore National Laboratory, Lawrence Berkeley National Laboratory, and University of California - Berkeley discovered that interplanetary dust particles (IDPs) could deliver water and organics to the Earth and other terrestrial planets.
People with arthritis experienced a ‘roller coaster' of emotions and saw their symptoms worsen during the Covid-19 lockdown – according to research from the University of East Anglia.
An alarming 22 percent of U.S. children live in poverty, which can have long-lasting negative consequences on brain development, emotional health and academic achievement. A new study, published July 20 in JAMA Pediatrics, provides even more compelling evidence that growing up in poverty has detrimental effects on the brain.
Lipocine Inc. announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent applications in support of its oral testosterone product for hypogonadism, also known as low testosterone (low T). These applications cover Lipocine's novel oral testosterone product (LPCN 1021) being developed to overcome the issues with currently marketed topical, parenteral, and transdermal testosterone products.
All approved therapy regimens to treat patients with hepatitis C are based on interferon, which must be injected. In this clinical trial to be presented at the annual meeting of the American Association for the Study of Liver Diseases, researchers treated patients - both treatment naive and experienced patients - with a twice daily oral combination therapy of a nucleoside polymerase and protease inhibitor.
› Verified 9 days ago
| Provider Name | Jessica Palmer, O.d., Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1730216805 PECOS PAC ID: 0345340204 Enrollment ID: O20070709000152 |
News Archive
Researchers from the University of Hawaii - Manoa (UHM) School of Ocean and Earth Science and Technology (SOEST), Lawrence Livermore National Laboratory, Lawrence Berkeley National Laboratory, and University of California - Berkeley discovered that interplanetary dust particles (IDPs) could deliver water and organics to the Earth and other terrestrial planets.
People with arthritis experienced a ‘roller coaster' of emotions and saw their symptoms worsen during the Covid-19 lockdown – according to research from the University of East Anglia.
An alarming 22 percent of U.S. children live in poverty, which can have long-lasting negative consequences on brain development, emotional health and academic achievement. A new study, published July 20 in JAMA Pediatrics, provides even more compelling evidence that growing up in poverty has detrimental effects on the brain.
Lipocine Inc. announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent applications in support of its oral testosterone product for hypogonadism, also known as low testosterone (low T). These applications cover Lipocine's novel oral testosterone product (LPCN 1021) being developed to overcome the issues with currently marketed topical, parenteral, and transdermal testosterone products.
All approved therapy regimens to treat patients with hepatitis C are based on interferon, which must be injected. In this clinical trial to be presented at the annual meeting of the American Association for the Study of Liver Diseases, researchers treated patients - both treatment naive and experienced patients - with a twice daily oral combination therapy of a nucleoside polymerase and protease inhibitor.
› Verified 9 days ago
| Provider Name | Double Oak Mountain Eyecare, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437659745 PECOS PAC ID: 9537414875 Enrollment ID: O20180611000272 |
News Archive
Researchers from the University of Hawaii - Manoa (UHM) School of Ocean and Earth Science and Technology (SOEST), Lawrence Livermore National Laboratory, Lawrence Berkeley National Laboratory, and University of California - Berkeley discovered that interplanetary dust particles (IDPs) could deliver water and organics to the Earth and other terrestrial planets.
People with arthritis experienced a ‘roller coaster' of emotions and saw their symptoms worsen during the Covid-19 lockdown – according to research from the University of East Anglia.
An alarming 22 percent of U.S. children live in poverty, which can have long-lasting negative consequences on brain development, emotional health and academic achievement. A new study, published July 20 in JAMA Pediatrics, provides even more compelling evidence that growing up in poverty has detrimental effects on the brain.
Lipocine Inc. announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent applications in support of its oral testosterone product for hypogonadism, also known as low testosterone (low T). These applications cover Lipocine's novel oral testosterone product (LPCN 1021) being developed to overcome the issues with currently marketed topical, parenteral, and transdermal testosterone products.
All approved therapy regimens to treat patients with hepatitis C are based on interferon, which must be injected. In this clinical trial to be presented at the annual meeting of the American Association for the Study of Liver Diseases, researchers treated patients - both treatment naive and experienced patients - with a twice daily oral combination therapy of a nucleoside polymerase and protease inhibitor.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rena C Lewis, 2617 Highway 31 S, Pelham, AL 35124-1322 Ph: (205) 664-1575 | Rena C Lewis, 2617 Highway 31 S, Pelham, AL 35124-1322 Ph: (205) 664-1575 |
News Archive
Researchers from the University of Hawaii - Manoa (UHM) School of Ocean and Earth Science and Technology (SOEST), Lawrence Livermore National Laboratory, Lawrence Berkeley National Laboratory, and University of California - Berkeley discovered that interplanetary dust particles (IDPs) could deliver water and organics to the Earth and other terrestrial planets.
People with arthritis experienced a ‘roller coaster' of emotions and saw their symptoms worsen during the Covid-19 lockdown – according to research from the University of East Anglia.
An alarming 22 percent of U.S. children live in poverty, which can have long-lasting negative consequences on brain development, emotional health and academic achievement. A new study, published July 20 in JAMA Pediatrics, provides even more compelling evidence that growing up in poverty has detrimental effects on the brain.
Lipocine Inc. announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent applications in support of its oral testosterone product for hypogonadism, also known as low testosterone (low T). These applications cover Lipocine's novel oral testosterone product (LPCN 1021) being developed to overcome the issues with currently marketed topical, parenteral, and transdermal testosterone products.
All approved therapy regimens to treat patients with hepatitis C are based on interferon, which must be injected. In this clinical trial to be presented at the annual meeting of the American Association for the Study of Liver Diseases, researchers treated patients - both treatment naive and experienced patients - with a twice daily oral combination therapy of a nucleoside polymerase and protease inhibitor.
› Verified 9 days ago
Eyecare Associates, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3429 Pelham Pkwy, Pelham, AL 35124 Phone: 205-663-3937 | |
West Point Optical Group Optometrist Medicare: Not Enrolled in Medicare Practice Location: 325 Huntley Pkwy, Pelham, AL 35124 Phone: 205-624-2015 | |
Dr. Douglas Curtis Clark, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2617 Highway 31 S, Pelham, AL 35124 Phone: 205-664-1575 Fax: 205-664-1578 | |
Kye L Mansfield, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3429 Pelham Pkwy, Pelham, AL 35124 Phone: 205-663-3937 | |
Dr. Kai Rinkowski, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2181 Pelham Parkway, Pelham, AL 35124 Phone: 205-987-0156 Fax: 205-987-0515 | |
Dr. James Brandon Perry, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2617 Highway 31 S, Pelham, AL 35124 Phone: 205-664-1575 Fax: 205-664-1578 |